Modulation of human Kv1.5 channel kinetics by N-cadherin

Biochemical and Biophysical Research Communications

Volumn 363, Issue 1, 2007, Pages 18-23

  Koutsouki, Evgenia ^a   Lam, Rebecca S ^a   Seebohm, Guiscard ^a   Ureche, Oana N ^a   Ureche, Liviu ^a   Baltaev, Ravshan ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Adhesion; Atrial fibrillation; Cell membrane potential; Heart; K+ channels

Indexed keywords

NERVE CELL ADHESION MOLECULE; POTASSIUM CHANNEL;

ANIMAL CELL; ARTICLE; BLOOD VESSEL TONE; CELL INTERACTION; CELL MEMBRANE; CONTROLLED STUDY; HEART MUSCLE POTENTIAL; MOLECULAR DYNAMICS; NONHUMAN; OOCYTE; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; XENOPUS;

ANIMALS; ANTIGENS, CD; CADHERINS; CELLS, CULTURED; HUMANS; ION CHANNEL GATING; KINETICS; KV1.5 POTASSIUM CHANNEL; MEMBRANE POTENTIALS; OOCYTES; XENOPUS LAEVIS;

EID: 34548789502     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.07.181     Document Type: Article

References (36)

1. + current in canine atrial myocytes. Circ. Res. 93 (2003) 744-751
2. Gaborit N., Le Bouter S., Szuts V., Varro A., Escande D., Nattel S., and Demolombe S. Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart. J. Physiol. (2007)
3. + channel in macrophages. J. Biol. Chem. 281 (2006) 37675-37685
4. Archer S.L., London B., Hampl V., Wu X., Nsair A., Puttagunta L., Hashimoto K., Waite R.E., and Michelakis E.D. Impairment of hypoxic pulmonary vasoconstriction in mice lacking the voltage-gated potassium channel Kv1.5. FASEB J. 15 (2001) 1801-1803
5. McGahon M.K., Dawicki J.M., Arora A., Simpson D.A., Gardiner T.A., Stitt A.W., Scholfield C.N., McGeown J.G., and Curtis T.M. Kv1.5 is a major component underlying the A-type potassium current in retinal arteriolar smooth muscle. Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H1001-H1008
6. Adda S., Fleischmann B.K., Freedman B.D., Yu M., Hay D.W., and Kotlikoff M.I. Expression and function of voltage-dependent potassium channel genes in human airway smooth muscle. J. Biol. Chem. 271 (1996) 13239-13243
7. + channel current. Circ. Res. 73 (1993) 210-216
8. Snyders D.J., Tamkun M.M., and Bennett P.B. A rapidly activating and slowly inactivating potassium channel cloned from human heart. Functional analysis after stable mammalian cell culture expression. J. Gen. Physiol. 101 (1993) 513-543
9. + current in cultured adult human atrial myocytes. Circ. Res. 80 (1997) 572-579
10. Brunner M., Kodirov S.A., Mitchell G.F., Buckett P.D., Shibata K., Folco E.J., Baker L., Salama G., Chan D.P., Zhou J., and Koren G. In vivo gene transfer of Kv1.5 normalizes action potential duration and shortens QT interval in mice with long QT phenotype. Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H194-H203
11. Nattel S., Yue L., and Wang Z. Cardiac ultrarapid delayed rectifiers: a novel potassium current family of functional similarity and molecular diversity. Cell Physiol. Biochem. 9 (1999) 217-226
12. Olson T.M., Alekseev A.E., Liu X.K., Park S., Zingman L.V., Bienengraeber M., Sattiraju S., Ballew J.D., Jahangir A., and Terzic A. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum. Mol. Genet. 15 (2006) 2185-2191
13. Eun J.S., Kim K.S., Kim H.N., Park S.A., Ma T.Z., Lee K.A., Kim D.K., Kim H.K., Kim I.S., Jung Y.H., Zee O.P., Yoo D.J., and Kwak Y.G. Synthesis of psoralen derivatives and their blocking effect of hKv1.5 channel. Arch. Pharm. Res. 30 (2007) 155-160
14. Lagrutta A., Wang J., Fermini B., and Salata J.J. Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current. J. Pharmacol. Exp. Ther. 317 (2006) 1054-1063
15. Hershman K.M., and Levitan E.S. Cell-cell contact between adult rat cardiac myocytes regulates Kv1.5 and Kv4.2 K+ channel mRNA expression. Am. J. Physiol 275 (1998) C1473-C1480
16. Mays D.J., Foose J.M., Philipson L.H., and Tamkun M.M. Localization of the Kv1.5 K+ channel protein in explanted cardiac tissue. J. Clin. Invest. 96 (1995) 282-292
17. Soler A.P., and Knudsen K.A. N-cadherin involvement in cardiac myocyte interaction and myofibrillogenesis. Dev. Biol. 162 (1994) 9-17
18. Volk T., and Geiger B. A 135-kd membrane protein of intercellular adherens junctions. EMBO J. 3 (1984) 2249-2260
19. Hertig C.M., Eppenberger-Eberhardt M., Koch S., and Eppenberger H.M. N-cadherin in adult rat cardiomyocytes in culture. I. Functional role of N-cadherin and impairment of cell-cell contact by a truncated N-cadherin mutant. J. Cell Sci. 109 Pt 1 (1996) 1-10
20. Volk T., Volberg T., Sabanay I., and Geiger B. Cleavage of A-CAM by endogenous proteinases in cultured lens cells and in developing chick embryos. Dev. Biol. 139 (1990) 314-326
21. Li J., Patel V.V., Kostetskii I., Xiong Y., Chu A.F., Jacobson J.T., Yu C., Morley G.E., Molkentin J.D., and Radice G.L. Cardiac-specific loss of N-cadherin leads to alteration in connexins with conduction slowing and arrhythmogenesis. Circ. Res. 97 (2005) 474-481
22. Kostetskii I., Li J., Xiong Y., Zhou R., Ferrari V.A., Patel V.V., Molkentin J.D., and Radice G.L. Induced deletion of the N-cadherin gene in the heart leads to dissolution of the intercalated disc structure. Circ. Res. 96 (2005) 346-354
23. Radice G.L., Rayburn H., Matsunami H., Knudsen K.A., Takeichi M., and Hynes R.O. Developmental defects in mouse embryos lacking N-cadherin. Dev. Biol. 181 (1997) 64-78
24. Ferreira-Cornwell M.C., Luo Y., Narula N., Lenox J.M., Lieberman M., and Radice G.L. Remodeling the intercalated disc leads to cardiomyopathy in mice misexpressing cadherins in the heart. J. Cell Sci. 115 (2002) 1623-1634
25. 2+ current via RhoA GTPase and Rho-associated kinase. J. Neurosci. 24 (2004) 10918-10923
26. Mason H.S., Latten M.J., Godoy L.D., Horowitz B., and Kenyon J.L. Modulation of Kv1.5 currents by protein kinase A, tyrosine kinase, and protein tyrosine phosphatase requires an intact cytoskeleton. Mol. Pharmacol. 61 (2002) 285-293
27. Murata M., Buckett P.D., Zhou J., Brunner M., Folco E., and Koren G. SAP97 interacts with Kv1.5 in heterologous expression systems. Am. J. Physiol. Heart Circ. Physiol. 281 (2001) H2575-H2584
28. Folco E.J., Liu G.X., and Koren G. Caveolin-3 and SAP97 form a scaffolding protein complex that regulates the voltage-gated potassium channel Kv1.5. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H681-H690
29. Choi W.S., Khurana A., Mathur R., Viswanathan V., Steele D.F., and Fedida D. Kv1.5 surface expression is modulated by retrograde trafficking of newly endocytosed channels by the dynein motor. Circ. Res. 97 (2005) 363-371
30. Eldstrom J., Choi W.S., Steele D.F., and Fedida D. SAP97 increases Kv1.5 currents through an indirect N-terminal mechanism. FEBS Lett. 547 (2003) 205-211
31. Cushman S.J., Nanao M.H., Jahng A.W., DeRubeis D., Choe S., and Pfaffinger P.J. Voltage dependent activation of potassium channels is coupled to T1 domain structure. Nat. Struct. Biol. 7 (2000) 403-407
32. + channels to distinct lipid raft populations. Targeting of Kv1.5 to caveolae. J. Biol. Chem. 276 (2001) 8409-8414
33. Causeret M., Taulet N., Comunale F., Favard C., and Gauthier-Rouviere C. N-cadherin association with lipid rafts regulates its dynamic assembly at cell-cell junctions in C2C12 myoblasts. Mol. Biol. Cell 16 (2005) 2168-2180
34. + channels by cell contact in a cloned folliculo-stellate cell (TtT/GF). Endocrinology 138 (1997) 4346-4350
35. 2+-activated potassium channels is involved in lysophosphatidylcholine-induced monocyte adhesion to endothelial cells. Atherosclerosis 190 (2007) 100-105
36. + channels inhibits adhesion and proliferation of hepatocarcinoma cells. Int. J. Mol. Med. 11 (2003) 261-266